circCACNA1D drives pulmonary fibrosis by regulating pyruvate kinase M2 dimer‑tetramer switching
International Journal of Molecular Medicine · 2026
DOI: 10.3892/ijmm.2026.5931 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Medicine, 2026. Verfasst von Yujie Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cellular and Genetic Medicine, Shandong Key Laboratory of Complex Medical Intelligence and Aging, Shandong Medical and Pharmaceutical U…. Hauptthemen laut MEDLINE: Pulmonary Fibrosis, Pyruvate Kinase, Protein Multimerization. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Pulmonary fibrosis is a progressive and fatal interstitial lung disease characterized by aberrant fibroblast activation and excessive extracellular matrix deposition. Circular RNAs (circRNAs) have emerged as critical regulators of fibrotic pathogenesis. However, their mechanistic roles remain incompletely defined. In the present study, circCACNA1D was identified as a novel driver of pulmonary fibrosis progression through direct interaction with pyruvate kinase M2 (PKM2). Specifically, circCACNA1D binds PKM2 and promotes its nuclear translocation and dimerization. This process is facilitated by desuccinylation at conserved lysine residues (K135, K166 and K270). The conformational shift from the tetrameric to the dimeric state reprograms cellular metabolism toward aerobic glycolysis and activates a pro‑fibrotic transcriptional program, including direct upregulation of KIF4A. In addition, the pharmacological stabilization of PKM2 tetramers with TEPP‑46 attenuated fibrotic phenotypes in vitro and alleviated bleomycin‑induced pulmonary fibrosis in mice. These findings define a previously unrecognized circRNA‑driven axis that coordinates PKM2 conformational switching, metabolic reprogramming and transcriptional activation, and suggest a potential therapeutic strategy for pulmonary fibrosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cellular and Genetic Medicine, Shandong Key Laboratory of Complex Medical Intelligence and Aging, Shandong Medical and Pharmaceutical University, Yantai, Shandong 264003, P.R. China.
- Department of Medical Laboratory, Yantai Affiliated Hospital of Shandong Medical and Pharmaceutical University, Yantai, Shandong 264000, P.R. China.
- Department of Respiratory and Critical Care Medicine, Shandong Medical and Pharmaceutical University Hospital, Shandong Medical and Pharmaceutical University, Binzhou, Shandong 256603, P.R. China.
Zitieren
APA
Wang, Y., Li, X., Wang, M., Zhai, N., Jiang, M., Liu, B., Lv, C., Zhang, S., Song, X., & Zhang, J. (2026). circCACNA1D drives pulmonary fibrosis by regulating pyruvate kinase M2 dimer‑tetramer switching. International Journal of Molecular Medicine. https://doi.org/10.3892/ijmm.2026.5931
Vancouver
Wang Y, Li X, Wang M, Zhai N, Jiang M, Liu B, et al. circCACNA1D drives pulmonary fibrosis by regulating pyruvate kinase M2 dimer‑tetramer switching. International Journal of Molecular Medicine. 2026. doi:10.3892/ijmm.2026.5931
BibTeX
@article{Wang2026,
author = {Wang, Yujie and Li, Xiaoting and Wang, Meirong and Zhai, Nailiang and Jiang, Mengqi and Liu, Bo and Lv, Changjun and Zhang, Songzi and Song, Xiaodong and Zhang, Jinjin},
title = {circCACNA1D drives pulmonary fibrosis by regulating pyruvate kinase M2 dimer‑tetramer switching},
journal = {International Journal of Molecular Medicine},
year = {2026},
doi = {10.3892/ijmm.2026.5931}
}
EUVIMED